LENZ Therapeutics, Inc.
LENZ • NASDAQ
LENZ Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Evert Schimmelpennink, with a market cap of $365.2M.
CEOEvert Schimmelpennink
Next Earnings
Upcoming earnings announcement for LENZ Therapeutics, Inc.
Date
Wednesday, May 6, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.92
Revenue Estimate
$3.4M
Earnings History
Past 7 earnings reports for LENZ Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2025 | Q3 2025 | -$0.59Est: -$0.68 | +13.2% | $12.5MEst: $5.4M | +132.1% |  10-Q |
| Jul 30, 2025 | Q2 2025 | -$0.53Est: -$0.67 | +20.9% | $5.0MEst: $4.2M | +19.6% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.53 | — | - | — | 10-Q |
| Mar 19, 2025 | Q4 2024 | -$0.46Est: -$0.40 | -15.0% | - | — | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.38Est: -$0.46 | +17.4% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.40 | — | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$3.53Est: -$0.84 | -320.2% | -Est: - | — | 10-Q |